Process Development and Scale-Up of a Novel Atypical DAT Inhibitor (S)‑CE-123

• Eduardo R. Perez Gonzalez,
• Bernhard Reck,
• Predrag Kalaba,
• Thierry Langer,
• Johann Leban,
• Gert Lubec

Affiliations

Eduardo R. Perez Gonzalez

Fine Organic Chemistry Lab, School of Sciences and Technology, São Paulo State University (UNESP), Presidente Prudente, São Paulo, Brazil

Bernhard Reck

ChemCon GmbH, Hamburg, Germany

Predrag Kalaba

Department of Pharmaceutical Sciences, Division of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Vienna, Austria

Thierry Langer

Department of Pharmaceutical Sciences, Division of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Vienna, Austria

Johann Leban

Department of Neuroproteomics, Paracelsus Medical University, Salzburg, Austria

Gert Lubec

Department of Neuroproteomics, Paracelsus Medical University, Salzburg, Austria